Viewing Study NCT01282268


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-01-03 @ 3:14 AM
Study NCT ID: NCT01282268
Status: COMPLETED
Last Update Posted: 2013-07-31
First Post: 2011-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Sponsor: Seaside Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fragile X Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fragile X syndrome View
None autism spectrum disorder View